May 20, 2014
The study, titled “Depression, antidepressant use and breast cancer risk,” will take place over two years and provide vital new information for doctors and patients considering the risks and benefits of antidepressants versus other depression treatments.
“Depression and antidepressant use are highly prevalent among U.S. women; so it is critically important to understand if depression and antidepressant use influence breast cancer risk,” notes Reeves.
The significance of the study goes beyond this too. “This will be the first study to comprehensively evaluate the relationships between depression, antidepressant use and breast cancer,” she adds. “Our hope is that the information from this study will help women and their doctors make informed decisions about treating depression, especially for women already at increased risk of breast cancer for reasons such as family history.”